The efficacy of rooibos Aspalathus linearis as an ergogenic aid during exercise
by Simeon E.H. Davies; Jeanine L. Marnewick; Sacha West; Mogammad Sharhidd Taliep; Fanie Rautenbach; Raeeq Gamieldien
International Journal of Human Factors and Ergonomics (IJHFE), Vol. 6, No. 1, 2019

Abstract: This study investigated whether rooibos herbal tea Aspalathus linearis has an ergogenic effect during a fatiguing arm strength test to exhaustion. Thirty-two male participants were randomised in a single blinded, cross-over placebo controlled study in which they ingested standardised rooibos or placebo capsules for four weeks prior to a fatiguing elbow flexion/extension exercise test entailing five sets/bouts of 15 repetitions of maximum voluntary contractions separated by 10-second rest intervals on a Biodex System 3 at a speed of 60° per second. Peak torque flexion (Nm) was consistently higher in the rooibos experimental (Re) compared to the placebo control (Pc) across the five exercise bouts, and this performance trend during flexion was also seen in the total work (joules) completed, although not significant (P > 0.05). It appears that the antioxidant properties of rooibos, may have contributed to an improvement in physical performance during a maximal isokinetic arm exercise protocol to induce fatigue.

Online publication date: Fri, 03-May-2019

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Human Factors and Ergonomics (IJHFE):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email